NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT04435964 2023-03-24G-DEFINERFondazione IRCCS Istituto Nazionale dei Tumori, MilanoCompleted247 enrolled